FierceBiotech Dec 5, 2025 Praxis claims efficacy success in phase 2 seizure trial, setting up approval talks with FDA
Endpoints News Dec 5, 2025 OTR Therapeutics gets $100M from Pfizer Ventures, others to build asset portfolio
BioPharma Dive Dec 5, 2025 Hemophilia gene therapies are struggling on the market, even as innovation soars
PLoS Biology Dec 5, 2025 Adaptive communication between cell assemblies and “reader” neurons shapes flexible brain dynamics
PLoS Biology Dec 5, 2025 The transcription factor SKN-1 drives lysosomal enlargement during aging to maintain function
PLoS Biology Dec 5, 2025 Correction: Catecholamines reduce choice history biases in perceptual decision making
Thermo Fisher Dec 5, 2025 Knuff & Co LLC Sells 3,559 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat